These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. Henneman P, Schaap FG, Havekes LM, Rensen PC, Frants RR, van Tol A, Hattori H, Smelt AH, van Dijk KW. Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114 [Abstract] [Full Text] [Related]
9. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population. Matsunaga A, Arishima H, Niimura H, Zhang B, Uehara Y, Ohwaki K, Morita M, Hayashida K, Saku K. Circ J; 2007 May; 71(5):746-52. PubMed ID: 17457003 [Abstract] [Full Text] [Related]
10. A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients. Kim M, Kim M, Yoo HJ, Lee E, Chae JS, Lee SH, Lee JH. PLoS One; 2017 May; 12(12):e0186693. PubMed ID: 29211729 [Abstract] [Full Text] [Related]
11. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis. Pi Y, Zhang L, Yang Q, Li B, Guo L, Fang C, Gao C, Wang J, Xiang J, Li J. Cerebrovasc Dis; 2012 May; 33(6):558-65. PubMed ID: 22688093 [Abstract] [Full Text] [Related]
17. Association of APOA5 -1131T>C polymorphism and serum lipid levels in patients with type 2 diabetes. Celap I, Simundic AM, Nikolac N, Kackov S, Katalinic D. DNA Cell Biol; 2013 Oct; 32(10):589-93. PubMed ID: 23919616 [Abstract] [Full Text] [Related]
19. Increased risk of obesity related to total energy intake with the APOA5-1131T > C polymorphism in Korean premenopausal women. Lim HH, Choi M, Kim JY, Lee JH, Kim OY. Nutr Res; 2014 Oct; 34(10):827-36. PubMed ID: 25263629 [Abstract] [Full Text] [Related]